Postprandial C-peptide is more relevant to hemoglobin A1c levels and diabetic microvascular complications than fasting C-peptide in type 2 diabetes

doi:10.4239/wjd.v16.i9.109414

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

(47)

(45)

(0)

(806)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Sep 15, 2025; 16(9): 109414
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.109414

Full Size Figure Download Figure

Figure 1 Flowchart of patient inclusion and exclusion criteria. FCP: Fasting C-peptide; T2DM: Type 2 diabetes mellitus; 2hCP: 2 hours postprandial C-peptide.

Citation: Wang Z, Deng MQ, Guo LX, Pan Q. Postprandial C-peptide is more relevant to hemoglobin A1c levels and diabetic microvascular complications than fasting C-peptide in type 2 diabetes. World J Diabetes 2025; 16(9): 109414
URL: https://www.wjgnet.com/1948-9358/full/v16/i9/109414.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i9.109414

Wang Z, Deng MQ, Guo LX, Pan Q. Postprandial C-peptide is more relevant to hemoglobin A1c levels and diabetic microvascular complications than fasting C-peptide in type 2 diabetes. World J Diabetes 2025; 16(9): 109414 [PMID: 40980302 DOI: 10.4239/wjd.v16.i9.109414]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.